Clinical Trial Details
| Trial ID: | L3287 |
| Source ID: | NCT01637935 |
| Associated Drug: | Pioglitazone |
| Title: | Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | YES |
| Results: | https://ClinicalTrials.gov/show/NCT01637935/results |
| Conditions: | Diabetes|Bladder Cancer |
| Interventions: | DRUG: Pioglitazone |
| Outcome Measures: | Primary: Incident Diagnosis of Bladder Cancer (10-year Analysis), Incident bladder cancers were identified from January 1, 1997 to December 31, 2012., January 1, 1997 to December 31, 2012 | Secondary: Incident Diagnosis of Bladder Cancer by Time Since Starting Pioglitazone (10 Year Analysis), January 1, 1997 to December 31, 2012|Incident Diagnosis of Bladder Cancer by Duration of Pioglitazone Therapy (10 Year Analysis), January 1, 1997 to December 31, 2012|Incident Diagnosis of Bladder Cancer by Cumulative Dose of Pioglitazone (10 Year Analysis), January 1, 1997 to December 31, 2012|Stage of Bladder Cancer (10 Year Analysis), January 1, 1997 to December 31, 2012 |
| Sponsor/Collaborators: | Sponsor: Takeda | Collaborators: Kaiser Permanente|Department of Epidemiology at University of Pennsylvania |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 193099 |
| Study Type: | OBSERVATIONAL |
| Study Designs: | Observational Model: |Time Perspective: p |
| Start Date: | 2004-07 |
| Completion Date: | 2014-08 |
| Results First Posted: | 2012-10-12 |
| Last Update Posted: | 2018-03-07 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT01637935 |
